XP Inc. Reports Strong 2025 Annual Results, Announces Significant Share Buyback, and Notes Rise in Contingent Liabilities
summarizeSummary
XP Inc. reported strong annual financial results for 2025, including increased net income and revenue, alongside significant share repurchases. The filing also highlighted a substantial rise in contingent liabilities.
check_boxKey Events
-
Strong Annual Financial Performance
XP Inc. reported a net income of R$5.17 billion for 2025, up from R$4.51 billion in 2024, and total revenue of R$18.40 billion, an increase from R$17.03 billion in the prior year.
-
Significant Share Repurchase Activity
The company repurchased R$1.90 billion in Class A common shares during 2025 and approved a new R$1.0 billion share buy-back program on November 17, 2025, extending until November 2026.
-
Increase in Contingent Liabilities
Possible contingent liabilities rose significantly to R$3.70 billion in 2025, up from R$2.48 billion in 2024, primarily related to tax, civil, and labor claims.
-
Minority Stake Acquisitions
XP Inc. acquired R$325.5 million in minority stakes in various Independent Financial Advisors (IFAs) during 2025, paid entirely in cash.
auto_awesomeAnalysis
XP Inc.'s annual financial statements for 2025 reveal robust growth in net income and total revenue, signaling strong operational performance. The company's substantial share repurchase activity, including a new R$1.0 billion program and R$1.9 billion in repurchases during 2025, demonstrates a commitment to returning capital to shareholders and may provide support for the stock price. However, a notable increase in possible contingent liabilities to R$3.7 billion presents a significant risk factor that investors should monitor, as these potential obligations could impact future financial health. The acquisition of minority stakes in IFAs indicates continued strategic expansion within its network.
At the time of this filing, XP was trading at $19.77 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $10.4B. The 52-week trading range was $12.20 to $20.98. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.